News

Filter

Current filters:

Merck & CoFinancial

1 to 9 of 66 results

NewLink earns $20 million Ebola vaccine milestone from Merck

19-02-2015

US biotech firm NewLink Genetics says it had received notification from pharma giant Merck & Co that…

BiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesVaccines

Merck & Co financials hit by patent expiries and strong dollar

Merck & Co financials hit by patent expiries and strong dollar

04-02-2015

US pharma giant Merck & Co reported 2014 financial, showing that revenue for the fourth quarter declined…

FinancialMerck & CoPharmaceutical

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

NewLink Genetic and Merck Ebola collaboration gets $30 million government award

23-12-2014

US biotech firm NewLink Genetics saw its shares gain 4.1% to $40.11 in morning trading on Monday, following…

Anti-viralsBiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesUSA

This week’s third quarter pharma financial results in brief

This week’s third quarter pharma financial results in brief

31-10-2014

Several pharma, biotech and generics makers announced their third quarter results this week. Here are…

AmgenBayerDr Reddy's LaboratoriesFinancialGilead SciencesIpsenMerck & CoNicOxNovartisNovo NordiskPfizerRecordatiSanofiShireTeva

Merck & Co third-qtr disappoints, as earnings plunge

Merck & Co third-qtr disappoints, as earnings plunge

27-10-2014

US pharma giant Merck & Co (NYSE: MRK) posted third-quarter 2014 financial results today, showing that…

FinancialKeytrudaMerck & CoOncologyPharmaceuticalRegulationUSA

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

29-07-2014

Global revenue at pharma giant Merck & Co slipped 1% but the company has still exceeded analysts’ estimates…

FinancialFinancial accountingGardasilHepatitis CIsentressMerckMerck & CoNasonexPharma giantPharmaceuticalRemicadeUSAVytorinZetia

Merck strengthens commitment to Chinese growth market

Merck strengthens commitment to Chinese growth market

23-07-2014

Germany’s Merck KGaA, a leading company for high-tech products in the pharmaceutical and chemical sectors,…

ChinaFinancialMerckMerck KGaAPharmaceuticalProductionResearch

1 to 9 of 66 results

COMPANY SPOTLIGHT

Menarini

Back to top